Landscape Reviews

ADC

Find out more about the ADCs on the cusp of approval, the ADCs we saw approved, enter the clinic, and be discontinued across 2021, get further insight into the record growth in the number of ADC trials and much more.

Download Here

Adoptive Cell

Discover key collaborations, investments, approvals in 2021 in the adoptive cell field—furthermore, a look to the future of the cell therapies space.

Download Here

Cancer Vaccine

Download a summary of key developments in 2021; regulatory announcements, discontinuation and first entries into the clinic.

Download Here

Bispecific

The following slides cover the analysis on the phase of trials, drugs in the clinic, drug discontinuations, and regulatory announcements in 2021.

Download Here

Checkpoint

Find out the most popular targets, the number of ICM clinical trials, and regulatory announcements in 2021.

Download Here

Cytokine

Don’t miss out on our overview of the clinically active cytokine space. This analysis includes the number of cytokine trials started per year and much more.

Download Here

DNA Damage Response

In this analysis, you will find key updates, regulatory announcements, and a summary of the current DDR landscape.

Download Here

Gene Therapy

Discover mergers and acquisitions, gene therapies that entered the preclinical space in 2021, and much more.

Download Here

Targeted Protein Degradation

The following slides look at the highlights from 2021, including drugs that entered the clinic, regulatory announcements, and collaborations.

Download Here

Oncolytic Viruses

The oncolytic virotherapy space continues to grow. Find below an overview analysis of the 2021 developments.

Download the Viral Vaccine Analysis Here
Download the Oncolytic Viruses Analysis Here

Beacon Solutions

ADC
Adoptive Cell
Bispecific
Cancer Vaccine
Checkpoint
Cytokine
DDR
Gene Therapy
RNA
Oncolytic Viruses
TPD
Beacon ADC Logo

 

Covering all Antibody Drug Conjugates (ADCs), Small Molecule Drug Conjugates (SMDCs), Protein Drug Conjugates (PDCs), Immunotoxins and more

Find out more

Beacon Adoptive Cell Logo

 

Covering all engineered and non-engineered immune cell therapies, including CAR-T, TCR, NK, TILs, Gamma-Delta T Cells and more

Find out more

Beacon Bispecific Logo

 

Covering all Bi- and Multi-Specific Antibodies, Antibody Fragments, Augmented Antibodies and more

Find out more

Cancer Vaccine Logo 2021

 

Beacon Cancer Vaccine provides the solution you need to master the prophylactic and therapeutic cancer vaccines field.

Find out more

Beacon Checkpoint Logo

 

Covering all Immune Checkpoint Combination Trials and Immune Checkpoint Modulators in development across 27 different checkpoint targets

Find out more

 

Covering all cytokines and drugs that target a cytokine or its immediate receptor belonging to the Interleukins, Interferons, Colony-stimulating factors, Transforming growth factor β, Tumour necrosis factor and Chemokines families.

Find out more

Beacon DDR Logo

 

Beacon DDR steps into the field to give drug developers the precise detailed view and broader picture of what is truly happening in the DDR field.

Find out more

Beacon Gene Therapy Logo

 

From gene-editing technologies, novel delivery systems, and a variety of genetic materials being used- Beacon Gene Therapy steps into the field to give drug developers a precise and detailed view of how the gene therapy landscape looks.

Find out more

 

Covering Oligonucleotide-based, mRNA-Based, Ribozyme, and gRNA-Mediated Gene Editing therapies, as well as RNA-Targeted Small Molecules – Beacon RNA covers all disease indications and many modalities to provide a detailed landscape of the RNA space.

Find out more

Beacon Oncolytic Viruses Logo

 

From capturing viral family and strains to understanding any genetic modifications – Beacon Oncolytic Viruses steps into the field to give drug developers the precise detailed view and broader picture of what is truly happening in the Oncolytic Virus field.

Find out more

Beacon TPD Logo

 

Beacon TPD provides the solution you need to master the targeted protein degradation field.

Find out more

About Beacon Targeted Therapies

We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.

 

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more

logo
Verified by MonsterInsights